Helsinn Investment Fund: Ten finalists have been chosen for the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology

NEXT STORY
Trident Brands, Brain Armor and NorthShore University HealthSystem Provide Update on Brain Health Research Collaboration
PREV STORY
Progressive Care Inc. Subsidiary PharmCo, LLC Earns Top Performance Scores From Humana Inc.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ContraFect Reports Third Quarter 2020 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News

TiGenix en Takeda kondigen aan dat Alofisel® (darvadstrocel) de goedkeuring krijgt voor de behandeling in Europa van complexe perianale fistels bij de ziekte van Crohn

PERSBERICHT GEREGLEMENTEERDE INFORMATIE VOORWETENSCHAP TiGenix en Takeda kondigen aan dat Alofisel® (darvadstrocel) de goedkeuring ...

author_avatar
NASDAQ Market News

AXIM® Biotechnologies Unveils First–in-Class COVID-19 Rapid Diagnostic Test for Neutralizing Antibodies and Files Pre-Emergency Use Authorization with the FDA

author_avatar
NASDAQ Market News